Uncomplicated urinary tract infection in dogs: 3-day short course vs conventional 10–14-day course — POSSIBLE (the treatment made no difference)

In dogs with uncomplicated bacterial urinary tract infection, is a 3-day short course non-inferior to a conventional 10–14-day course for clinical and microbiological cure?

Shelf #140 · gate-verified and displayed under the developer's blinded-trial rule

POSSIBLE (the treatment made no difference): In two randomised blinded trials, a 3-day course cured uncomplicated canine urinary tract infection at rates that did not differ from a conventional longer beta-lactam course. In Westropp 2012 (68 dogs), high-dose enrofloxacin for 3 days gave microbiologic cure of 77.1% vs 81.2% on 14 days of amoxicillin-clavulanic acid, and clinical cure of 88.6% vs 87.9%, meeting the trial's noninferiority margin. In Clare 2014 (38 female dogs), 3 days of trimethoprim-sulfamethoxazole followed by 7 days of placebo gave clinical and microbiological cure rates with no statistically significant difference from 10 days of cephalexin — but long-term cure rates were low in both groups (clinical cure >30 days after treatment ended: 50% short-course vs 65% long-course). Neither trial shortened the same drug: in both, the 3-day arm was a different antimicrobial from the long-course comparator, so this shelf answers 'a 3-day regimen vs a conventional regimen', not 'the same drug for less time'. The samples are small and Clare studied females only, which is why the no-difference stamp is POSSIBLE rather than higher. Drafted Nov 10, 2026 (VetMed build, topic #140); all figures from abstracts fetched and verified at drafting.

Clare 2014: 3 days of trimethoprim-sulfamethoxazole + 7 days of placebo vs 10 days of cephalexin in 38 female dogs — no difference in cure, and long-term cure was low on both

Randomized, double-blinded, placebo-controlled clinical trial (record's own Methods wording)

Who: Dogs: 38 client-owned female dogs with uncomplicated bacterial cystitis. Dogs were treated with trimethoprim-sulfamethoxazole (TMP-SMX; 15 mg/kg PO q12h for 3 days followed by a placebo capsule PO q12h for 7 days; Group SDS; n = 20) or cephalexin (20 mg/kg PO q12h for 10 days; Group LDBL; n = 18), and monitored for clinical and microbiological cure during treatment and at short- and long-term follow-up.

Result: No statistically significant differences were found between treatment groups in clinical cure rates after 3 days of treatment (89% SDS, 94% LDBL; P = 1.00) and 4 days (85% SDS, 72% LDBL; P = .44) or >30 days (50% SDS, 65% LDBL; P = .50) after conclusion of treatment, or in microbiological cure rates 4 days (59% SDS, 36% LDBL; P = .44) or >30 days (44% SDS, 20% LDBL; P = .40) after conclusion of treatment. The authors conclude they did not identify a difference in cure rates between short-duration sulfonamide and long-duration beta-lactam treatments, and that long-term cure rates in both treatment groups were low.

Watch out: Female dogs only, and only 38 of them — the confidence around every comparison is wide, and the long-term figures point in opposite directions for clinical cure (50% vs 65%, favouring the long course) and microbiological cure (44% vs 20%, favouring the short course), all non-significant. The comparison also changes the drug as well as the duration (TMP-SMX vs cephalexin), so it cannot isolate an effect of duration alone. The low long-term cure in both arms is itself a finding: in some female dogs, 'uncomplicated' bacterial cystitis may be more complicated than previously recognised, in the authors' words.

Clare S, Hartmann FA, Jooss M, Bachar E, Wong YY, Trepanier LA, Viviano KR. Short- and long-term cure rates of short-duration trimethoprim-sulfamethoxazole treatment in female dogs with uncomplicated bacterial cystitis. J Vet Intern Med. 2014;28(3):818-26. PMID: 24673608. Registry ID: none in the record. MeSH: Animals · Anti-Infective Agents, Urinary · Cystitis · Dog Diseases · Dogs · Double-Blind Method · Female · Recurrence · Time Factors · Treatment Outcome · Trimethoprim, Sulfamethoxazole Drug Combination

Westropp 2012: high-dose enrofloxacin for 3 days was not inferior to 14 days of amoxicillin-clavulanic acid in 68 dogs

Prospective, multicenter, controlled, randomized blinded clinical trial (record's own Methods wording); indexed as Randomized Controlled Trial, with MeSH Double-Blind Method

Who: Dogs: client-owned adult, otherwise healthy dogs with uncomplicated urinary tract infection and aerobic bacterial urine culture yielding ≥ 10(3) CFU/mL of bacteria after cystocentesis, in a prospective, multicenter trial. Enrolled dogs were randomized to group 1 (enrofloxacin 18–20 mg/kg PO q24h for 3 days; n = 35) or group 2 (amoxicillin-clavulanic acid 13.75–25 mg/kg PO q12h for 14 days; n = 33). Urine cultures were obtained at days 0, 10, and 21, and microbiologic and clinical cure rates were evaluated 7 days after antimicrobial treatment was discontinued.

Result: The microbiologic cure rate was 77.1% for group 1 and 81.2% for group 2, respectively — an absolute difference of about 4 percentage points. The clinical cure rate was 88.6% for group 1 and 87.9% for group 2, respectively. Cure rates between groups did not differ according to the selected margin of noninferiority. The authors conclude that high-dose short-duration enrofloxacin treatment was not inferior to a conventional amoxicillin-clavulanic acid protocol for the treatment of uncomplicated bacterial urinary tract infection in dogs.

Watch out: This is the trial that matches the 'high-dose' wording of the shelf's question — the 3-day arm is high-dose enrofloxacin, a fluoroquinolone — and, as in Clare 2014, the short arm is a different drug from the long-course comparator, not the same drug given for fewer days. Noninferiority was judged against the trial's selected margin, which the abstract does not state numerically. Fluoroquinolone stewardship considerations are outside what this trial measured; the authors themselves call for further research on whether the protocol decreases the emergence of antimicrobial resistance.

Westropp JL, Sykes JE, Irom S, Daniels JB, Smith A, Keil D, Settje T, Wang Y, Chew DJ. Evaluation of the efficacy and safety of high dose short duration enrofloxacin treatment regimen for uncomplicated urinary tract infections in dogs. J Vet Intern Med. 2012;26(3):506-12. PMID: 22486931. Registry ID: none in the record. MeSH: Animals · Anti-Bacterial Agents · Colony Count, Microbial · Dog Diseases · Dogs · Double-Blind Method · Enrofloxacin · Female · Fluoroquinolones · Male · Prospective Studies · Urinary Tract Infections

Synthesis: two blinded trials, two different drug pairs — short regimens cured as often, long-term cure was the weak point in both arms

Synthesis

Who: Synthesis of the cards above: Clare 2014 (randomized, double-blinded, placebo-controlled; 38 female dogs; 3-day trimethoprim-sulfamethoxazole + 7-day placebo vs 10-day cephalexin) and Westropp 2012 (prospective, multicenter, randomized blinded; 68 dogs; 3-day high-dose enrofloxacin vs 14-day amoxicillin-clavulanic acid).

Result: On short-term cure the two trials agree: roughly 77–89% microbiologic and clinical cure on the 3-day regimens vs 81–88% on the conventional courses in Westropp, and no significant separation on any cure measure in Clare. The honest limits are shared by both: each trial changed the drug along with the duration, the total evidence base is 106 dogs, Clare covers females only, and Clare's long-term cure rates (>30 days after treatment) were low whichever regimen was used. Together that supports POSSIBLE (the treatment made no difference) for short-term cure — the extra days bought no shown extra cure — without claiming the duration question is closed for every drug or every dog.

Watch out: Neither trial studied complicated urinary tract infection, male dogs with prostatic involvement (Clare was females only), or shortening a course of the same antimicrobial — do not read this shelf beyond uncomplicated infection and the two regimens actually tested.

Synthesis of Clare S et al. PMID: 24673608; Westropp JL et al. PMID: 22486931. Registry IDs as on the individual cards.

Back to the library index · VetMed home

VetMed is an educational resource, not veterinary advice.